Research Associate

Dr Caitlin Murphy

Medicine & Health
School of Clinical Medicine
  • Journal articles | 2022
    Murphy CE; Walker AK; O’Donnell M; Galletly C; Lloyd AR; Liu D; Weickert CS; Weickert TW, 2022, 'Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases', Translational Psychiatry, 12,
    Journal articles | 2022
    Zhu Y; Owens SJ; Murphy CE; Ajulu K; Rothmond D; Purves-Tyson T; Middleton F; Webster MJ; Weickert CS, 2022, 'Inflammation-related transcripts define “high” and “low” subgroups of individuals with schizophrenia and bipolar disorder in the midbrain', Brain, Behavior, and Immunity, 105, pp. 149 - 159,
    Journal articles | 2022
    Zhu Y; Webster MJ; Murphy CE; Middleton FA; Massa PT; Liu C; Dai R; Weickert CS, 2022, 'Distinct Phenotypes of Inflammation Associated Macrophages and Microglia in the Prefrontal Cortex Schizophrenia Compared to Controls', Frontiers in Neuroscience, 16,
    Journal articles | 2021
    Murphy CE; Walker AK; Weickert CS, 2021, 'Neuroinflammation in schizophrenia: the role of nuclear factor kappa B', Translational Psychiatry, 11, pp. 528,
    Journal articles | 2021
    Murphy CE; Weickert CS, 2021, 'A new suspect in the unsolved case of neuroinflammation in schizophrenia', Molecular Psychiatry, 26, pp. 7105 - 7106,
    Journal articles | 2020
    Murphy CE; Kondo Y; Walker AK; Rothmond DA; Matsumoto M; Shannon Weickert C, 2020, 'Regional, cellular and species difference of two key neuroinflammatory genes implicated in schizophrenia', Brain, Behavior, and Immunity, 88, pp. 826 - 839,
    Journal articles | 2020
    Murphy CE; Lawther AJ; Webster MJ; Asai M; Kondo Y; Matsumoto M; Walker AK; Weickert CS, 2020, 'Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines', Journal of Neuroinflammation, 17, pp. 215,
    Journal articles | 2019
    Murphy CE; Walker AK; Shannon Weickert C, 2019, 'Where There's Smoke, There's Fire—But Who Is Lighting the Match? Bolstering Transcriptional Evidence for the Role of Nuclear Factor-κB in Neuroimmune Activation in Schizophrenia', Biological Psychiatry, 85, pp. 5 - 7,
    Journal articles | 2018
    Owens SJ; Murphy CE; Purves-Tyson TD; Weickert TW; Shannon Weickert C, 2018, 'Considering the role of adolescent sex steroids in schizophrenia', Journal of Neuroendocrinology, 30,
  • Conference Abstracts | 2019
    Murphy C; Kondo Y; Rothmond DA; Matsumoto M; Weickert CS, 2019, 'Decreased cortical human immunodeficiency virus type i enhancer binding protein 2 in schizophrenia is driven by patients with high inflammation', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER, DENMARK, Copenhagen, Vol. 29, pp. S155 - S156, presented at 32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP), DENMARK, Copenhagen, 07 September 2019 - 10 September 2019,